Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tudor Arvinte

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 12, 2011
Addressing new analytical challenges in protein formulation developmentHenryk Mach, Tudor Arvinte
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 14, 2005
Where disease pathogenesis meets protein formulation: renal deposition of immunoglobulin aggregatesBarthélemy Demeule, Robert Gurny, Tudor Arvinte
Drug Discovery Today. Technologies|July 2, 2014
High-throughput formulation screening of therapeutic proteinsMartinus A H Capelle, Tudor Arvinte
International Journal of Pharmaceutics|September 29, 2006
Detection and characterization of protein aggregates by fluorescence microscopyBarthélemy Demeule, Robert Gurny, Tudor Arvinte
Pharmaceutical Research|July 5, 2008
A high throughput protein formulation platform: case study of salmon calcitoninMartinus A H Capelle, Robert Gurny, Tudor Arvinte
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 17, 2006
High throughput screening of protein formulation stability: practical considerationsMartinus A H Capelle, Robert Gurny, Tudor Arvinte
Vaccine|February 12, 2005
Spectroscopic characterization of antibodies adsorbed to aluminium adjuvants: correlation with antibody vaccine immunogenicityMartinus A H Capelle, Peter Brügger, Tudor Arvinte
International Journal of Pharmaceutics|November 13, 2007
High throughput methods to characterize protein permeation and releaseMartinus A H Capelle, Robert Gurny, Tudor Arvinte
Mabs|January 12, 2010
New methods allowing the detection of protein aggregates: a case study on trastuzumabBarthélemy Demeule, Caroline Palais, Gia Machaidze, et al.
Journal of Pharmaceutical Sciences|November 25, 2014
Influence of protein formulation and carrier solution on asymmetrical flow field-flow fractionation: a case study of the plant-produced recombinant anthrax protective antigen pp-PA83Caroline Palais, Jessica A Chichester, Slobodanka Manceva, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 12, 2011
Addressing new analytical challenges in protein formulation developmentHenryk Mach, Tudor Arvinte
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 14, 2005
Where disease pathogenesis meets protein formulation: renal deposition of immunoglobulin aggregatesBarthélemy Demeule, Robert Gurny, Tudor Arvinte
Drug Discovery Today. Technologies|July 2, 2014
High-throughput formulation screening of therapeutic proteinsMartinus A H Capelle, Tudor Arvinte
International Journal of Pharmaceutics|September 29, 2006
Detection and characterization of protein aggregates by fluorescence microscopyBarthélemy Demeule, Robert Gurny, Tudor Arvinte
Pharmaceutical Research|July 5, 2008
A high throughput protein formulation platform: case study of salmon calcitoninMartinus A H Capelle, Robert Gurny, Tudor Arvinte
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 17, 2006
High throughput screening of protein formulation stability: practical considerationsMartinus A H Capelle, Robert Gurny, Tudor Arvinte
Vaccine|February 12, 2005
Spectroscopic characterization of antibodies adsorbed to aluminium adjuvants: correlation with antibody vaccine immunogenicityMartinus A H Capelle, Peter Brügger, Tudor Arvinte
International Journal of Pharmaceutics|November 13, 2007
High throughput methods to characterize protein permeation and releaseMartinus A H Capelle, Robert Gurny, Tudor Arvinte
Mabs|January 12, 2010
New methods allowing the detection of protein aggregates: a case study on trastuzumabBarthélemy Demeule, Caroline Palais, Gia Machaidze, et al.
Journal of Pharmaceutical Sciences|November 25, 2014
Influence of protein formulation and carrier solution on asymmetrical flow field-flow fractionation: a case study of the plant-produced recombinant anthrax protective antigen pp-PA83Caroline Palais, Jessica A Chichester, Slobodanka Manceva, et al.
Pageof 4